Rapt Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Rapt Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapt Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapt Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.9M | 276k | 24.85 |
| 2023-09-30 | $4.6M | 277k | 16.62 |
| 2022-09-30 | $288k | 12k | 24.06 |
| 2022-06-30 | $219k | 12k | 18.25 |
| 2021-12-31 | $538k | 15k | 36.73 |
| 2021-09-30 | $455k | 15k | 31.05 |
| 2021-06-30 | $226k | 7.1k | 31.79 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas